IPSC
NASDAQ · Biotechnology
Century Therapeutics Inc
$1.93
-0.03 (-1.53%)
Open$1.98
Previous Close$1.96
Day High$2.03
Day Low$1.91
52W High$3.04
52W Low$0.44
Volume—
Avg Volume576.0K
Market Cap348.08M
P/E Ratio—
EPS$-1.11
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+1,317.1% upside
Current
$1.93
$1.93
Target
$27.35
$27.35
$22.03
$27.35 avg
$42.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 227.46M | 24.41M | 24.82M |
| Net Income | -19,965,278 | -1,389,193 | -1,166,783 |
| Profit Margin | -8.8% | -5.7% | -4.7% |
| EBITDA | -8,693,102 | -1,777,503 | -1,974,923 |
| Free Cash Flow | — | -1,484,406 | -1,631,995 |
| Rev Growth | +175.9% | +22.2% | +16.0% |
| Debt/Equity | — | 0.27 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |